• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

bianca.devitt@unimelb.edu.au

Credentials


Position
Honorary Principal Fellow
Department of Clinical Pathology
ORCID

0000-0002-7854-4302

Bianca Devitt

Honorary Principal Fellow
Department of Clinical Pathology

32 Scholarly works
0 Projects

HIGHLIGHTS

  • 2023

    Journal article

    Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA)
    DOI: 10.1002/ijc.34245
  • 2022

    Conference Proceedings

    CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR ) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort
  • 2021

    Journal article

    A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial
    DOI: 10.1182/blood-2021-149308
  • 2021

    Conference Proceedings

    Real world outcomes in elderly women with HER2 positive advanced breast cancer
  • 2021

    Journal article

    The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study
    DOI: 10.1016/S2666-7568(20)30036-2
  • 2020

    Journal article

    Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer
    DOI: 10.1111/ajco.13381
  • 2020

    Conference Proceedings

    Real world outcomes in elderly patients with HER2 positive advanced breast cancer
Bianca Devitt

RECENT SCHOLARLY WORKS

  • 2020

    Conference Proceedings

    Real world outcomes in elderly women with HER2-positive advanced breast cancer
    DOI: 10.1016/j.annonc.2020.10.071
  • 2020

    Journal article

    Understanding patients’ attitudes toward cancer multidisciplinary meetings: A mixed methods study
    DOI: 10.1200/JOP.19.00274
  • 2020

    Conference Proceedings

    Pertuzumab study for HER2-positive non-metastatic breast cancer in the neoadjuvant setting in Australia: Interim analysis
    DOI: 10.1158/1538-7445.SABCS19-P1-18-15

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224